中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
中国医药(600056) 利润表
单位:万元
报表日期2021-09-302021-06-302021-03-312020-12-312020-09-30
一、营业总收入2,672,805.271,826,534.52857,190.523,931,175.353,026,727.48
营业收入2,672,805.271,826,534.52857,190.523,931,175.353,026,727.48
二、营业总成本2,553,620.091,732,273.40823,722.083,638,646.042,831,986.25
营业成本2,300,433.071,557,204.65736,520.933,251,222.792,539,585.13
营业税金及附加7,228.765,007.322,596.8611,730.048,318.01
销售费用164,056.81115,289.7758,432.98248,456.23198,372.39
管理费用63,627.1742,448.2221,416.1093,121.2463,779.90
财务费用14,659.879,883.053,720.6525,735.9117,785.03
研发费用3,614.412,440.381,034.568,379.834,145.80
资产减值损失----------
公允价值变动收益------65.5720.81
投资收益4,920.481,169.67-654.803,751.435,388.01
其中:对联营企业和合营企业的投资收益7,262.912,590.33271.138,830.626,338.26
汇兑收益----------
三、营业利润125,780.5796,567.3435,653.25193,918.66190,429.24
加:营业外收入1,141.49517.60323.41889.92717.16
减:营业外支出784.92716.81160.862,281.972,345.39
其中:非流动资产处置损失----------
四、利润总额126,137.1496,368.1335,815.80192,526.60188,801.01
减:所得税费用24,927.1218,797.678,923.4853,918.5547,176.09
五、净利润101,210.0377,570.4626,892.32138,608.05141,624.92
归属于母公司所有者的净利润83,561.3066,103.7121,294.51131,064.57123,805.57
少数股东损益17,648.7211,466.765,597.827,543.4817,819.36
六、每股收益
基本每股收益(元/股)0.78210.61870.19931.22661.1587
稀释每股收益(元/股)0.78210.61870.19931.22661.1587
七、其他综合收益-8.4010.42---346.72-16.39
八、综合收益总额101,201.6277,580.8826,892.32138,261.33141,608.53
归属于母公司所有者的综合收益总额83,552.9066,114.1321,294.51130,730.58123,789.17
归属于少数股东的综合收益总额17,648.7211,466.765,597.827,530.7517,819.36
下载全部历史数据到excel中 返回页顶